Verification of smad3 targets miRNA by luciferase assay

Publish Year: 1393
نوع سند: مقاله کنفرانسی
زبان: English
View: 940

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

CIGS13_0588

تاریخ نمایه سازی: 7 بهمن 1393

Abstract:

SMAD3 gene encodes a protein that belongs to the SMAD family. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions as a transcriptional modulator activated by transforming growth factor-beta (TGF-beta) and is thought to play a role in the regulation of carcinogenesis. Mutations in SMAD3 gene have been associated with patients of type I Loeys-Dietz syndrome, idiopathic pulmonary fibrosis,aneurysms-osteoarthritis syndrome (AOS) and colorectal cancer (CRC). Our research shows that several different MRE formultiple miRNA is located in this region . A newly discovered Trkc-miR2 is one of them. In this study, the 3-UTR region ofSMAD3 gene and genomic fragment containing Trkc-miR2 were cloned in Psicheck-2 and PEGFP-C1,respectively. Dual luciferase test to examine the direct interaction of the miRNA and the 3-UTR was performed. The results indicate that the SMAD3 gene is a direct target of Trkc-miR2.

Authors

Meisam Jafarzadeh

Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Bahram Mohammad Soltani

Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Sadat Dokanehiifard

Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran